Calcium signaling in pancreatic β-cells in health and in Type 2 diabetes

Cell Calcium

Volumn 56, Issue 5, 2014, Pages 340-361

  Gilon, Patrick ^a   Chae, Hee Young ^a   Rutter, Guy A ^b   Ravier, Magalie A ^c,d  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

^c INSTITUT DE GÉNOMIQUE FONCTIONNELLE   (France)

^d UNIV MONTPELLIER   (France)

Author keywords

Calcium signaling; Diabetes; Cells

Indexed keywords

ADENOSINE TRIPHOSPHATE; CALCIUM ION; GLUCOSE; INSULIN; VOLTAGE GATED CALCIUM CHANNEL; CALCIUM;

ACIDITY; BIOSYNTHESIS; CALCIUM CELL LEVEL; CALCIUM CURRENT; CALCIUM HOMEOSTASIS; CALCIUM SIGNALING; CALCIUM TRANSPORT; CELL FUNCTION; CELL METABOLISM; CELL ORGANELLE; CELL STIMULATION; CYTOSOL; ENDOPLASMIC RETICULUM; ENVIRONMENTAL FACTOR; EXTRACELLULAR MATRIX; GOLGI COMPLEX; HUMAN; INSULIN RELEASE; LIFESTYLE; LYSOSOME; METABOLIC RATE; MITOCHONDRION; MOLECULAR PROBE; MONOGENIC DISORDER; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; REVIEW; SECRETORY GRANULE; GENETICS; METABOLISM; PANCREAS ISLET; PATHOLOGY;

CALCIUM; CALCIUM SIGNALING; DIABETES MELLITUS, TYPE 2; ENDOPLASMIC RETICULUM; GLUCOSE; HUMANS; INSULIN; INSULIN-SECRETING CELLS; ISLETS OF LANGERHANS;

EID: 84912127169     PISSN: 01434160     EISSN: 15321991     Source Type: Journal    
DOI: 10.1016/j.ceca.2014.09.001     Document Type: Review

References (345)

1. Kahn S.E., Zraika S., Utzschneider K.M., Hull R.L. The beta cell lesion in type 2 diabetes: there has to be a primary functional abnormality. Diabetologia 2009, 52:1003-1012.
2. Cabrera O., Berman D.M., Kenyon N.S., et al. The unique cytoarchitecture of human pancreatic islets has implications for islet cell function. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:2334-2339.
3. Brissova M., Fowler M.J., Nicholson W.E., et al. Assessment of human pancreatic islet architecture and composition by laser scanning confocal microscopy. J. Histochem. Cytochem. 2005, 53:1087-1097.
4. Bosco D., Armanet M., Morel P., et al. Unique arrangement of alpha- and beta-cells in human islets of Langerhans. Diabetes 2010, 59:1202-1210.
5. Steiner D.J., Kim A., Miller K., Hara M. Pancreatic islet plasticity: interspecies comparison of islet architecture and composition. Islets 2010, 2:135-145.
6. Kilimnik G., Kim A., Jo J., et al. Quantification of pancreatic islet distribution in situ in mice. Am. J. Physiol. Endocrinol. Metab. 2009, 297:E1331-E1338.
7. Wiederkehr A., Wollheim C.B. Impact of mitochondrial calcium on the coupling of metabolism to insulin secretion in the pancreatic beta-cell. Cell Calcium 2008, 44:64-76.
8. Sekine N., Cirulli V., Regazzi R., et al. Low lactate dehydrogenase and high mitochondrial glycerol phosphate dehydrogenase in pancreatic beta-cells. Potential role in nutrient sensing. J. Biol. Chem. 1994, 269:4895-4902.
9. 2+ uniporter MCU is essential for glucose-induced ATP increases in pancreatic beta-cells. PLOS ONE 2012, 7:e39722.
10. 2+. Diabetologia 2013, 56:1577-1586.
11. Henquin J.C. Do pancreatic beta cells "taste" nutrients to secrete insulin?. Sci. Signal. 2012, 5:36.
12. Henquin J.C., Nenquin M., Ravier M.A., Szollosi A. Shortcomings of current models of glucose-induced insulin secretion. Diabetes Obes. Metab. 2009, 11(Suppl. 4):168-179.
13. Gilon P., Rorsman P. NALCN: a regulated leak channel. EMBO Rep. 2009, 10:963-964.
14. Rorsman P., Eliasson L., Kanno T., et al. Electrophysiology of pancreatic beta-cells in intact mouse islets of Langerhans. Prog. Biophys. Mol. Biol. 2011, 107:224-235.
15. 2+ buffering and electrical activity in mouse pancreatic beta-cells. Biophys. J. 1999, 76:2018-2028.
16. Rorsman P., Braun M., Zhang Q. Regulation of calcium in pancreatic alpha- and beta-cells in health and disease. Cell Calcium 2012, 51:300-308.
17. Braun M., Ramracheya R., Bengtsson M., et al. Voltage-gated ion channels in human pancreatic beta-cells: electrophysiological characterization and role in insulin secretion. Diabetes 2008, 57:1618-1628.
18. 2+ currents in human pancreatic islet beta-cells: evidence for roles in the generation of action potentials and insulin secretion. Pflugers Arch. 1995, 431:272-282.
19. Drews G., Krippeit-Drews P., Dufer M. Electrophysiology of islet cells. Adv. Exp. Med. Biol. 2010, 654:115-163.
20. Houamed K.M., Sweet I.R., Satin L.S. BK channels mediate a novel ionic mechanism that regulates glucose-dependent electrical activity and insulin secretion in mouse pancreatic beta-cells. J. Physiol. 2010, 588:3511-3523.
21. Jacobson D.A., Mendez F., Thompson M., et al. Calcium-activated and voltage-gated potassium channels of the pancreatic islet impart distinct and complementary roles during secretagogue induced electrical responses. J. Physiol. 2010, 588:3525-3537.
22. Yang S.N., Shi Y., Yang G., et al. Ionic mechanisms in pancreatic beta cell signaling. Cell. Mol. Life Sci. 2014, (in press). 10.1007/s00018-014-1680-6.
23. 2+. Cell Calcium 2012, 52:28-35.
24. 2+-dependent mechanism. Diabetes 2002, 51(Suppl. 1):S162-S170.
25. 2+ contributes to oscillations of the membrane potential in pancreatic beta-cells. Diabetes 2002, 51:376-384.
26. Kanno T., Rorsman P., Gopel S.O. Glucose-dependent regulation of rhythmic action potential firing in pancreatic beta-cells by K(ATP)-channel modulation. J. Physiol. 2002, 545:501-507.
27. Ren J., Sherman A., Bertram R., et al. Slow oscillations of KATP conductance in mouse pancreatic islets provide support for electrical bursting driven by metabolic oscillations. Am. J. Physiol. Endocrinol. Metab. 2013, 305:E805-E817.
28. Gilon P., Ravier M.A., Jonas J.C., Henquin J.C. Control mechanisms of the oscillations of insulin secretion in vitro and in vivo. Diabetes 2002, 51(Suppl. 1):S144-S151.
29. Bertram R., Sherman A., Satin L.S. Electrical bursting, calcium oscillations, and synchronization of pancreatic islets. Adv. Exp. Med. Biol. 2010, 654:261-279.
30. Manning Fox J.E., Gyulkhandanyan A.V., Satin L.S., Wheeler M.B. Oscillatory membrane potential response to glucose in islet beta-cells: a comparison of islet-cell electrical activity in mouse and rat. Endocrinology 2006, 147:4655-4663.
31. i oscillations in single human pancreatic islets. Cell Calcium 1996, 20:409-414.
32. 2+ signalling and insulin release in human pancreatic beta cells. Diabetologia 1994, 37(Suppl. 2):S11-S20.
33. Kindmark H., Kohler M., Arkhammar P., et al. Oscillations in cytoplasmic free calcium concentration in human pancreatic islets from subjects with normal and impaired glucose tolerance. Diabetologia 1994, 37:1121-1131.
34. Roma L.P., Pascal S.M., Duprez J., Jonas J.C. Mitochondrial oxidative stress contributes differently to rat pancreatic islet cell apoptosis and insulin secretory defects after prolonged culture in a low non-stimulating glucose concentration. Diabetologia 2012, 55:2226-2237.
35. Gilon P., Jonas J.C., Henquin J.C. Culture duration and conditions affect the oscillations of cytoplasmic calcium concentration induced by glucose in mouse pancreatic islets. Diabetologia 1994, 37:1007-1014.
36. + channels owing to a knockout of the pore-forming subunit Kir6.2. Endocrinology 2009, 150:33-45.
37. Brown G.R., Kohler M., Berggren P.O. Parallel changes in nuclear and cytosolic calcium in mouse pancreatic beta-cells. Biochem. J. 1997, 325(Pt 3):771-778.
38. 2+ signals in cytosol and nucleus in pancreatic beta-cells. Diabetes 2004, 53(Suppl. 1):S92-S95.
39. Yang S.N., Berggren P.O. The role of voltage-gated calcium channels in pancreatic beta-cell physiology and pathophysiology. Endocr. Rev. 2006, 27:621-676.
40. 2+ channel null mice. EMBO J. 2003, 22:3844-3854.
41. 2+ channels in pancreatic beta cells. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:10164-10169.
42. 2+ channels. J. Clin. Invest. 2004, 113:1430-1439.
43. 2+ currents by acetylcholine in mouse pancreatic B-cells. J. Physiol. 1997, 499(Pt 1):65-76.
44. Davalli A.M., Biancardi E., Pollo A., et al. Dihydropyridine-sensitive and -insensitive voltage-operated calcium channels participate in the control of glucose-induced insulin release from human pancreatic beta cells. J. Endocrinol. 1996, 150:195-203.
45. 2+, diphenylamine-2-carboxylate, and glucose metabolism. J. Biol. Chem. 1994, 269:17095-17103.
46. 2+ exchange in insulin release from mouse pancreatic islets. Am. J. Physiol. 1996, 271:E426-E433.
47. Jing X., Li D.Q., Olofsson C.S., et al. CaV2.3 calcium channels control second-phase insulin release. J. Clin. Invest. 2005, 115:146-154.
48. Islam M.S. Calcium signaling in the islets. Adv. Exp. Med. Biol. 2010, 654:235-259.
49. Sher E., Giovannini F., Codignola A., et al. Voltage-operated calcium channel heterogeneity in pancreatic beta cells: physiopathological implications. J. Bioenerg. Biomembr. 2003, 35:687-696.
50. 2+ microdomains and the control of insulin secretion. Cell Calcium 2006, 40:539-551.
51. 2+ measurements in mouse pancreatic beta cells support the existence of an amplifying effect of glucose on insulin secretion. Diabetologia 2010, 53:1947-1957.
52. 2+ channels from secretory vesicles. Diabetes 2010, 59:1192-1201.
53. 2+ channels from secretory granules. Cell Metab. 2009, 10:455-465.
54. 2+ microgradients in mouse pancreatic islet cells. J. Physiol. 2000, 525(Pt 1):159-167.
55. 2+ channel is functionally coupled to the exocytotic machinery. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:248-253.
56. Pinton P., Tsuboi T., Ainscow E.K., et al. Dynamics of glucose-induced membrane recruitment of protein kinase C beta II in living pancreatic islet beta-cells. J. Biol. Chem. 2002, 277:37702-37710.
57. 2+ in the vicinity of secretory granules. Biochem. J. 1998, 330(Pt 3):1399-1404.
58. Eliasson L., Abdulkader F., Braun M., et al. Novel aspects of the molecular mechanisms controlling insulin secretion. J. Physiol. 2008, 586:3313-3324.
59. Kang Y., Huang X., Pasyk E.A., et al. Syntaxin-3 and syntaxin-1A inhibit L-type calcium channel activity, insulin biosynthesis and exocytosis in beta-cell lines. Diabetologia 2002, 45:231-241.
60. 2+ channels by distinct domains within SNAP-25. Diabetes 2002, 51:1425-1436.
61. Henquin J.C. Triggering and amplifying pathways of regulation of insulin secretion by glucose. Diabetes 2000, 49:1751-1760.
62. Henquin J.C. Regulation of insulin secretion: a matter of phase control and amplitude modulation. Diabetologia 2009, 52:739-751.
63. Fridlyand L.E., Jacobson D.A., Philipson L.H. Ion channels and regulation of insulin secretion in human beta-cells: a computational systems analysis. Islets 2013, 5:1-15.
64. Jacobson D.A., Philipson L.H. TRP channels of the pancreatic beta cell. Handb. Exp. Pharmacol. 2007, 409-424.
65. Islam M.S. TRP channels of islets. Adv. Exp. Med. Biol. 2011, 704:811-830.
66. Colsoul B., Vennekens R., Nilius B. Transient receptor potential cation channels in pancreatic beta cells. Rev. Physiol. Biochem. Pharmacol. 2011, 161:87-110.
67. Uchida K., Tominaga M. The role of thermosensitive TRP (transient receptor potential) channels in insulin secretion. Endocr. J. 2011, 58:1021-1028.
68. Nilius B., Owsianik G. The transient receptor potential family of ion channels. Genome Biol. 2011, 12:218.
69. Nilius B., Owsianik G., Voets T., Peters J.A. Transient receptor potential cation channels in disease. Physiol. Rev. 2007, 87:165-217.
70. -/- mice. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:5208-5213.
71. Gilon P., Henquin J.C. Mechanisms and physiological significance of the cholinergic control of pancreatic beta-cell function. Endocr. Rev. 2001, 22:565-604.
72. Wuttke A., Idevall-Hagren O., Tengholm A. P2Y(1) receptor-dependent diacylglycerol signaling microdomains in beta cells promote insulin secretion. FASEB J. 2013, 27:1610-1620.
73. 2+ and insulin oscillations, and basal insulin release. Diabetes 2005, 54:1798-1807.
74. 2+ as evidences in single pancreatic islets. J. Biol. Chem. 1993, 268:22265-22268.
75. 2+ and insulin release in glucose-stimulated pancreatic islets. J. Biol. Chem. 1994, 269:8749-8753.
76. Serre-Beinier V., Bosco D., Zulianello L., et al. Cx36 makes channels coupling human pancreatic beta-cells, and correlates with insulin expression, Hum Mol Genet 2009, 18:428-439.
77. 2+ concentration oscillatory patterns in identified alpha- and beta-cells within intact human islets of Langerhans. Diabetes 2006, 55:2463-2469.
78. Hodson D.J., Mitchell R.K., Bellomo E.A., et al. Lipotoxicity disrupts incretin-regulated human beta cell connectivity. J. Clin. Invest. 2013, 123:4182-4194.
79. 2+-ATPase in beta-cell function and diabetes. Adv. Exp. Med. Biol. 2013, 961:385-394.
80. Chen L., Koh D.S., Hille B. Dynamics of calcium clearance in mouse pancreatic beta-cells. Diabetes 2003, 52:1723-1731.
81. 2+ outflow and entry in the rat pancreatic beta-cell: studies with antisense oligonucleotides. Diabetes 1998, 47:1873-1880.
82. Nguidjoe E., Sokolow S., Bigabwa S., et al. Heterozygous inactivation of the Na/Ca exchanger increases glucose-induced insulin release, beta-cell proliferation, and mass, Diabetes 2011, 60:2076-2085.
83. 2+-transport ATPases. Chem. Rev. 2009, 109:4733-4759.
84. 2+ ion extruded. J. Physiol. 2009, 587:315-327.
85. 2+-ATPase are differentially expressed in normal and diabetic islets of Langerhans. Biochem. J. 1996, 319(Pt 2):521-527.
86. 2+ homeostasis in pancreatic beta-cells. Diabetes 2002, 51:3245-3253.
87. Evans-Molina C., Robbins R.D., Kono T., et al. Peroxisome proliferator-activated receptor gamma activation restores islet function in diabetic mice through reduction of endoplasmic reticulum stress and maintenance of euchromatin structure. Mol. Cell. Biol. 2009, 29:2053-2067.
88. 2+-ATPase (SERCA)-2b and -3. Diabetes 2004, 53:1517-1525.
89. 2+-ATPase of the endoplasmic reticulum. Am. J. Physiol. Cell Physiol. 2006, 290:C1503-C1511.
90. 2+ homeostasis revealed by RNA silencing. Diabetes 2004, 53:393-400.
91. Mekahli D., Bultynck G., Parys J.B., et al. Endoplasmic-reticulum calcium depletion and disease. Cold Spring Harb. Perspect. Biol. 2011, 3.
92. 2+ pumps of the endoplasmic reticulum and Golgi apparatus. Cold Spring Harb. Perspect. Biol. 2011, 3.
93. Prins D., Michalak M. Organellar calcium buffers. Cold Spring Harb. Perspect. Biol. 2011, 3.
94. Coe H., Michalak M. Calcium binding chaperones of the endoplasmic reticulum. Gen. Physiol. Biophys. 2009, 28:F96-F103. (Spec No Focus).
95. 2+ storage in health and disease: a dynamic equilibrium. Cell Calcium 2010, 47:297-314.
96. c and role of SERCA2b and SERCA3. Diabetes 2011, 60:2533-2545.
97. Lytton J., Westlin M., Burk S.E., et al. Functional comparisons between isoforms of the sarcoplasmic or endoplasmic reticulum family of calcium pumps. J. Biol. Chem. 1992, 267:14483-14489.
98. 2+ in the endoplasmic reticulum of mouse pancreatic beta cells. J. Biol. Chem. 1999, 274:36883-36890.
99. 2+ in mouse islets of Langerhans. Am. J. Physiol. 1994, 266:E852-E862.
100. 2+ concentration in an electrically excitable cell, the insulin-secreting pancreatic B-cell. J. Biol. Chem. 1992, 267:20713-20720.
101. 2+ influx in the electrically excitable pancreatic B-cell. J. Biol. Chem. 1999, 274:20197-20205.
102. c response in mouse pancreatic islets. Am. J. Physiol. Endocrinol. Metab. 2002, 282:E982-E991.
103. 2+ pool in mouse pancreatic beta-cells. J. Physiol. 2004, 559:141-156.
104. 2+ and the ATP/ADP ratio: a feedback control mechanism in mouse pancreatic islets. Biochem. J. 1998, 333(Pt 2):269-274.
105. 2+ concentration in the store lumen. EMBO J. 1998, 17:435-442.
106. Shannon T.R., Ginsburg K.S., Bers D.M. Reverse mode of the sarcoplasmic reticulum calcium pump and load-dependent cytosolic calcium decline in voltage-clamped cardiac ventricular myocytes. Biophys. J. 2000, 78:322-333.
107. 2+ release mechanism in A7r5 cells regulated by calmodulin-like proteins. J. Biol. Chem. 2003, 278:27548-27555.
108. 2+ release mechanism mediated by neither inositol trisphosphate nor ryanodine receptors. Biochem. J. 2002, 361:605-611.
109. 2+ ATPases (SERCA) pumps silently refill the endoplasmic reticulum. J. Biol. Chem. 2007, 282:11456-11464.
110. 2+ entry in endothelial cells. Cell Calcium 2007, 41:63-76.
111. Berridge M.J., Bootman M.D., Roderick H.L. Calcium signalling: dynamics, homeostasis and remodelling. Nat. Rev. Mol. Cell Biol. 2003, 4:517-529.
112. 2+ release channels. Physiol. Rev. 2007, 87:593-658.
113. Ivanova H., Vervliet T., Missiaen L., et al. Inositol 1,4,5-trisphosphate receptor-isoform diversity in cell death and survival. Biochim. Biophys. Acta 2014, 1843(10):2164-2183.
114. Cheng H., Wang S.Q. Calcium signaling between sarcolemmal calcium channels and ryanodine receptors in heart cells. Front. Biosci. 2002, 7. d1867-d1878.
115. Murayama T., Ogawa Y. Roles of two ryanodine receptor isoforms coexisting in skeletal muscle. Trends Cardiovasc. Med. 2002, 12:305-311.
116. Lee H.C. Cyclic ADP-ribose and nicotinic acid adenine dinucleotide phosphate (NAADP) as messengers for calcium mobilization. J. Biol. Chem. 2012, 287:31633-31640.
117. 2+ signaling occurs via second messenger release from intraorganelle synthesis sites. Curr. Biol. 2008, 18:1612-1618.
118. 2+ from islet microsomes. J. Biol. Chem. 1997, 272:3133-3136.
119. Thomas J.M., Masgrau R., Churchill G.C., Galione A. Pharmacological characterization of the putative cADP-ribose receptor. Biochem. J. 2001, 359:451-457.
120. Hohenegger M., Suko J., Gscheidlinger R., et al. Nicotinic acid-adenine dinucleotide phosphate activates the skeletal muscle ryanodine receptor. Biochem. J. 2002, 367:423-431.
121. 2+ from a thapsigargin-sensitive store in the nuclear envelope by activating ryanodine receptors. J. Cell Biol. 2003, 163:271-282.
122. 2+ signaling in T-lymphocytes. J. Biol. Chem. 2005, 280:21394-21399.
123. 2+ signaling in the pancreatic beta-cell. Islets 2010, 2:323-330.
124. Blondel O., Takeda J., Janssen H., et al. Sequence and functional characterization of a third inositol trisphosphate receptor subtype, IP3R-3, expressed in pancreatic islets, kidney, gastrointestinal tract, and other tissues. J. Biol. Chem. 1993, 268:11356-11363.
125. Lee B., Bradford P.G., Laychock S.G. Characterization of inositol 1,4,5-trisphosphate receptor isoform mRNA expression and regulation in rat pancreatic islets, RINm5F cells and betaHC9 cells. J. Mol. Endocrinol. 1998, 21:31-39.
126. Lee B., Jonas J.C., Weir G.C., Laychock S.G. Glucose regulates expression of inositol 1,4,5-trisphosphate receptor isoforms in isolated rat pancreatic islets. Endocrinology 1999, 140:2173-2182.
127. De Smedt H., Missiaen L., Parys J.B., et al. Determination of relative amounts of inositol trisphosphate receptor mRNA isoforms by ratio polymerase chain reaction. J. Biol. Chem. 1994, 269:21691-21698.
128. Lee B., Laychock S.G. Inositol 1,4,5-trisphosphate receptor isoform expression in mouse pancreatic islets: effects of carbachol. Biochem. Pharmacol. 2001, 61:327-336.
129. 2+ channel expression in INS-1 and rat pancreatic beta cells. World J. Gastroenterol. 2009, 15:3046-3050.
130. Satin L.S., Kinard T.A. Neurotransmitters and their receptors in the islets of Langerhans of the pancreas: what messages do acetylcholine, glutamate, and GABA transmit?. Endocrine 1998, 8:213-223.
131. 2+-ATPase (SERCA)-2 and ryanodine receptors. Diabetes 2002, 51(Suppl. 1):S190-S201.
132. Johnson J.D., Kuang S., Misler S., Polonsky K.S. Ryanodine receptors in human pancreatic beta cells: localization and effects on insulin secretion. FASEB J. 2004, 18:878-880.
133. 2+ signaling system stimulated by the insulinotropic hormone glucagon-like peptide-1-(7-37). J. Biol. Chem. 1999, 274:14147-14156.
134. Islam M.S. The ryanodine receptor calcium channel of beta-cells: molecular regulation and physiological significance. Diabetes 2002, 51:1299-1309.
135. Dror V., Kalynyak T.B., Bychkivska Y., et al. Glucose and endoplasmic reticulum calcium channels regulate HIF-1beta via presenilin in pancreatic beta-cells. J. Biol. Chem. 2008, 283:9909-9916.
136. Islam M.S., Leibiger I., Leibiger B., et al. In situ activation of the type 2 ryanodine receptor in pancreatic beta cells requires cAMP-dependent phosphorylation. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:6145-6150.
137. Johnson J.D., Han Z., Otani K., et al. RyR2 and calpain-10 delineate a novel apoptosis pathway in pancreatic islets. J. Biol. Chem. 2004, 279:24794-24802.
138. Bruton J.D., Lemmens R., Shi C.L., et al. Ryanodine receptors of pancreatic beta-cells mediate a distinct context-dependent signal for insulin secretion. FASEB J. 2003, 17:301-303.
139. 2+ release from insulin-containing vesicles in living pancreatic beta-cells (MIN6). J. Biol. Chem. 2003, 278:11057-11064.
140. 2+ pool in the insulin secreting cell line INS-1. FEBS Lett. 1999, 446:309-312.
141. Dixit S.S., Wang T., Manzano E.J., et al. Effects of CaMKII-mediated phosphorylation of ryanodine receptor type 2 on islet calcium handling, insulin secretion, and glucose tolerance. PLOS ONE 2013, 8:e58655.
142. Takasawa S., Kuroki M., Nata K., et al. A novel ryanodine receptor expressed in pancreatic islets by alternative splicing from type 2 ryanodine receptor gene. Biochem. Biophys. Res. Commun. 2010, 397:140-145.
143. 2+ channels but not the ryanodine receptor. Biochem. J. 1995, 306(Pt 3):679-686.
144. 2+ oscillations induced by carbachol and guanosine 5'-O-(3-thiotriphosphate) in hyperpolarized pancreatic beta-cells. Naunyn. Schmiedebergs Arch. Pharmacol. 1994, 349:503-509.
145. 2+ release via inositol 1,4,5-trisphosphate receptors is amplified by protein kinase A and triggers exocytosis in pancreatic beta-cells. J. Biol. Chem. 2004, 279:45455-45461.
146. 2+ release by activation of inositol 1,4,5-trisphosphate receptors in primary pancreatic beta-cells. Cell Calcium 2004, 36:1-9.
147. 2+ signaling events in pancreatic beta-cells. FASEB J. 2005, 19:301-303.
148. Bhattacharyya M.L., Sarker S., Seth K. Ryanodine induced block of a cloned human cardiac potassium channel. J. Mol. Cell. Cardiol. 1995, 27:1931-1935.
149. 2+ release in insulin-secreting cells. FEBS Lett. 1992, 296:287-291.
150. Islam M.S., Larsson O., Berggren P.O. Cyclic ADP-ribose in beta cells. Science 1993, 262:584-586.
151. 2+ responses in rat pancreatic beta-cells. Cell Calcium 1995, 18:411-419.
152. Choi K.J., Cho D.S., Kim J.Y., et al. Ca-induced Ca release from internal stores in INS-1 rat insulinoma cells. Korean J. Physiol. Pharmacol. 2011, 15:53-59.
153. 2+ stores in insulin-secreting cells: lack of effect of cADP ribose. Cell Calcium 1994, 16:71-80.
154. 2+ stores in individual pancreatic beta-cells. Diabetes 1998, 47:1224-1230.
155. 2+ stores in individual pancreatic beta-cells permeabilized or not with digitonin or alpha-toxin. Cell Calcium 2000, 27:43-51.
156. 2+ from the endoplasmic reticulum and an acidic store in rat pancreatic beta cells. Cell Calcium 2012, 51:140-148.
157. Hellman B. Pulsatility of insulin release-a clinically important phenomenon. Ups. J. Med. Sci. 2009, 114:193-205.
158. Liu Y.J., Grapengiesser E., Gylfe E., Hellman B. Crosstalk between the cAMP and inositol trisphosphate-signalling pathways in pancreatic beta-cells. Arch. Biochem. Biophys. 1996, 334:295-302.
159. 2+ in mouse pancreatic islets. J. Physiol. 1998, 508(Pt 2):471-481.
160. i oscillations in glucose-stimulated beta-cells from ob/ob mice. J. Biol. Chem. 1994, 269:1120-1124.
161. 2+ transients. Endocrine 2001, 15:73-78.
162. 2+ channels in pancreatic beta-cells. J. Biol. Chem. 2001, 276:9971-9977.
163. 2+ release by reversible phosphorylation and dephosphorylation. Biochim. Biophys. Acta 2009, 1793:959-970.
164. 2+-mediated generation of inositol 1,4,5-triphosphate and inositol 1,3,4,5-tetrakisphosphate in pancreatic islets. Studies with K+, glucose, and carbamylcholine. J. Biol. Chem. 1987, 262:3567-3571.
165. 2+ influx in insulin-secreting cells. J. Biol. Chem. 2004, 279:19396-19400.
166. Tamarina N.A., Kuznetsov A., Rhodes C.J., et al. Inositol (1,4,5)-trisphosphate dynamics and intracellular calcium oscillations in pancreatic beta-cells. Diabetes 2005, 54:3073-3081.
167. Rhee S.G. Regulation of phosphoinositide-specific phospholipase C. Annu. Rev. Biochem 2001, 70:281-312.
168. Kugler G., Weiss R.G., Flucher B.E., Grabner M. Structural requirements of the dihydropyridine receptor alpha1S II-III loop for skeletal-type excitation-contraction coupling. J. Biol. Chem. 2004, 279:4721-4728.
169. Seino S., Chen L., Seino M., et al. Cloning of the alpha 1 subunit of a voltage-dependent calcium channel expressed in pancreatic beta cells. Proc. Natl. Acad. Sci. U. S. A. 1992, 89:584-588.
170. 2+-dependent insulin secretion from the islets of Langerhans. Endocrine 2000, 13:251-262.
171. 2+ channels in insulin-secreting mouse pancreatic B cells. Biophys. J. 2001, 81:3308-3323.
172. Marks A.R. Calcium cycling proteins and heart failure: mechanisms and therapeutics. J. Clin. Invest. 2013, 123:46-52.
173. Okamoto H., Takasawa S. Recent advances in the Okamoto model: the CD38-cyclic ADP-ribose signal system and the regenerating gene protein (Reg)-Reg receptor system in beta-cells. Diabetes 2002, 51(Suppl. 3):S462-S473.
174. Kajimoto Y., Miyagawa J., Ishihara K., et al. Pancreatic islet cells express BST-1, a CD38-like surface molecule having ADP-ribosyl cyclase activity. Biochem. Biophys. Res. Commun. 1996, 219:941-946.
175. Takasawa S., Nata K., Yonekura H., Okamoto H. Cyclic ADP-ribose in insulin secretion from pancreatic beta cells. Science 1993, 259:370-373.
176. i, and insulin secretion. J. Biol. Chem. 1999, 274:1869-1872.
177. Noguchi N., Yoshikawa T., Ikeda T., et al. FKBP12.6 disruption impairs glucose-induced insulin secretion. Biochem. Biophys. Res. Commun. 2008, 371:735-740.
178. Kato I., Takasawa S., Akabane A., et al. Regulatory role of CD38 (ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase) in insulin secretion by glucose in pancreatic beta cells. Enhanced insulin secretion in CD38-expressing transgenic mice. J. Biol. Chem. 1995, 270:30045-30050.
179. 2+ store in neuroendocrine cells with a vesicle-associated membrane protein aequorin chimaera. J. Cell Biol. 2001, 155:41-51.
180. Chen Z., Li Z., Wei B., et al. FKBP12.6-knockout mice display hyperinsulinemia and resistance to high-fat diet-induced hyperglycemia. FASEB J. 2010, 24:357-363.
181. Johnson J.D., Ford E.L., Bernal-Mizrachi E., et al. Suppressed insulin signaling and increased apoptosis in CD38-null islets. Diabetes 2006, 55:2737-2746.
182. Malaisse W.J., Kanda Y., Inageda K., et al. Cyclic ADP-ribose measurements in rat pancreatic islets. Biochem. Biophys. Res. Commun. 1997, 231:546-548.
183. Scruel O., Wada T., Kontani K., et al. Effects of d-glucose and starvation upon the cyclic ADP-ribose content of rat pancreatic islets. Biochem. Mol. Biol. Int. 1998, 45:783-790.
184. 2+ concentration in the pancreatic beta-cell are independent of cyclic ADP-ribose. J. Biol. Chem. 1996, 271:19074-19079.
185. 2+ entry. Adv. Exp. Med. Biol. 2012, 740:349-382.
186. Stathopulos P.B., Zheng L., Li G.Y., et al. Structural and mechanistic insights into STIM1-mediated initiation of store-operated calcium entry. Cell 2008, 135:110-122.
187. 2+ entry. Nat. Cell Biol. 2009, 11:669-677.
188. Putney J.W. Alternative forms of the store-operated calcium entry mediators, STIM1 and Orai1. Curr. Top. Membr. 2013, 71:109-123.
189. Putney J.W. Origins of the concept of store-operated calcium entry. Front. Biosci. (Schol Ed.) 2011, 3:980-984.
190. Shen W.W., Frieden M., Demaurex N. Remodelling of the endoplasmic reticulum during store-operated calcium entry. Biol. Cell. 2011, 103:365-380.
191. 2+ entry. Curr. Top. Membr. 2013, 71:149-179.
192. Montell C. The TRP superfamily of cation channels. Sci. STKE 2005, 2005:re3.
193. Park C.Y., Shcheglovitov A., Dolmetsch R. The CRAC channel activator STIM1 binds and inhibits L-type voltage-gated calcium channels. Science 2010, 330:101-105.
194. 2+ in pancreatic beta-cells exhibits graded dependence on the filling of the endoplasmic reticulum. J. Cell Sci. 2001, 114:2179-2186.
195. 2+ entry in mouse pancreatic beta-cells by both direct and indirect mechanisms. J. Physiol. 1997, 503(Pt 2):387-398.
196. 2+ entry in insulin-releasing pancreatic beta-cells. Cell Calcium 1997, 22:277-286.
197. 2+ entry (SOCE) in islet cells. J. Biol. Chem. 2012, 287:9862-9872.
198. Tamarina N.A., Kuznetsov A., Philipson L.H. Reversible translocation of EYFP-tagged STIM1 is coupled to calcium influx in insulin secreting beta-cells. Cell Calcium 2008, 44:533-544.
199. 2+ stores activates a maitotoxin-sensitive nonselective cationic current in beta-cells. J. Biol. Chem. 1994, 269:32055-32058.
200. i oscillations in transgenically derived beta-cells. J. Biol. Chem. 1998, 273:10402-10410.
201. Sakura H., Ashcroft F.M. Identification of four trp1 gene variants murine pancreatic beta-cells. Diabetologia 1997, 40:528-532.
202. Qian F., Huang P., Ma L., et al. TRP genes: candidates for nonselective cation channels and store-operated channels in insulin-secreting cells. Diabetes 2002, 51(Suppl. 1):S183-S189.
203. Worley J.F., McIntyre M.S., Spencer B., et al. Endoplasmic reticulum calcium store regulates membrane potential in mouse islet beta-cells. J. Biol. Chem. 1994, 269:14359-14362.
204. 2+ store-operated and -independent ionic currents in insulin-secreting HIT-T15 cells and mouse pancreatic beta-cells. J. Membr. Biol. 2004, 197:59-70.
205. 2+ signaling. Trends Cell Biol. 2010, 20:277-286.
206. 2+ depletion from granules inhibits exocytosis. A study with insulin-secreting cells. J. Biol. Chem. 1998, 273:19002-19008.
207. Llopis J., McCaffery J.M., Miyawaki A., et al. Measurement of cytosolic, mitochondrial, and Golgi pH in single living cells with green fluorescent proteins. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:6803-6808.
208. Missiaen L., Dode L., Vanoevelen J., et al. Calcium in the Golgi apparatus. Cell Calcium 2007, 41:405-416.
209. 2+ homeostasis of the trans-Golgi compartment. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:9198-9203.
210. 2+ store, with functional properties distinct from those of the endoplasmic reticulum. EMBO J. 1998, 17:5298-5308.
211. 2+ accumulation in the Golgi apparatus of HeLa cells assessed via RNA-mediated interference. Biochem. Biophys. Res. Commun. 2003, 306:430-436.
212. Chandra S., Fewtrell C., Millard P.J., et al. Imaging of total intracellular calcium and calcium influx and efflux in individual resting and stimulated tumor mast cells using ion microscopy. J. Biol. Chem. 1994, 269:15186-15194.
213. Pezzati R., Bossi M., Podini P., et al. High-resolution calcium mapping of the endoplasmic reticulum-Golgi-exocytic membrane system. Electron energy loss imaging analysis of quick frozen-freeze dried PC12 cells. Mol. Biol. Cell 1997, 8:1501-1512.
214. 2+ signalling: a new route to NAADP. Biochem. J. 2008, 411:e1-e3.
215. 2+ signaling and endolysosomal trafficking. Curr. Biol. 2010, 20:703-709.
216. Calcraft P.J., Ruas M., Pan Z., et al. NAADP mobilizes calcium from acidic organelles through two-pore channels. Nature 2009, 459:596-600.
217. Wang X., Zhang X., Dong X.P., et al. TPC proteins are phosphoinositide-activated sodium-selective ion channels in endosomes and lysosomes. Cell 2012, 151:372-383.
218. Cang C., Bekele B., Ren D. The voltage-gated sodium channel TPC1 confers endolysosomal excitability. Nat. Chem. Biol. 2014, 10:463-469.
219. Duman J.G., Chen L., Palmer A.E., Hille B. Contributions of intracellular compartments to calcium dynamics: implicating an acidic store. Traffic 2006, 7:859-872.
220. Johnson J.D., Misler S. Nicotinic acid-adenine dinucleotide phosphate-sensitive calcium stores initiate insulin signaling in human beta cells. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:14566-14571.
221. 2+ responses in clonal pancreatic beta cells. Curr. Biol. 2003, 13:247-251.
222. Rutter G.A. Calcium signalling: NAADP comes out of the shadows. Biochem. J. 2003, 373:e3-e4.
223. 2+ signals in pancreatic acinar and beta cells. J. Biol. Chem. 2004, 279:7234-7240.
224. Naylor E., Arredouani A., Vasudevan S.R., et al. Identification of a chemical probe for NAADP by virtual screening. Nat. Chem. Biol. 2009, 5:220-226.
225. Park K.H., Kim B.J., Shawl A.I., et al. Autocrine/paracrine function of nicotinic acid adenine dinucleotide phosphate (NAADP) for glucose homeostasis in pancreatic beta-cells and adipocytes. J. Biol. Chem. 2013, 288:35548-35558.
226. Hutton J.C., Penn E.J., Peshavaria M. Low-molecular-weight constituents of isolated insulin-secretory granules. Bivalent cations, adenine nucleotides and inorganic phosphate. Biochem. J. 1983, 210:297-305.
227. Ravazzola M., Halban P.A., Orci L. Inositol 1,4,5-trisphosphate receptor subtype 3 in pancreatic islet cell secretory granules revisited. Proc. Natl. Acad. Sci. U. S. A. 1996, 93:2745-2748.
228. 2+ from rat insulinoma microsomes by inositol-1,4,5-trisphosphate. Nature 1984, 309:562-564.
229. 2+-dependent regulation of mitochondrial dynamics by the Miro-Milton complex. Int. J. Biochem. Cell Biol. 2009, 41:1972-1976.
230. 2+ within electropermeabilized insulin-secreting cells (INS-1). Biochim. Biophys. Acta 1992, 1175:107-113.
231. Ravier M.A., Eto K., Jonkers F.C., et al. The oscillatory behavior of pancreatic islets from mice with mitochondrial glycerol-3-phosphate dehydrogenase knockout. J. Biol. Chem. 2000, 275:1587-1593.
232. Casimir M., Rubi B., Frigerio F., et al. Silencing of the mitochondrial NADH shuttle component aspartate-glutamate carrier AGC1/Aralar1 in INS-1E cells and rat islets. Biochem. J. 2009, 424:459-466.
233. Eto K., Tsubamoto Y., Terauchi Y., et al. Role of NADH shuttle system in glucose-induced activation of mitochondrial metabolism and insulin secretion. Science 1999, 283:981-985.
234. Wiederkehr A., Wollheim C.B. Mitochondrial signals drive insulin secretion in the pancreatic beta-cell. Mol. Cell. Endocrinol. 2012, 353:128-137.
235. 2+ homeostasis: mechanism, role, and tissue specificities. Pflugers Arch. 2012, 464:3-17.
236. Rizzuto R., De Stefani D., Raffaello A., Mammucari C. Mitochondria as sensors and regulators of calcium signalling. Nat. Rev. Mol. Cell Biol. 2012, 13:566-578.
237. Groschner L.N., Alam M.R., Graier W.F. Metabolism-secretion coupling and mitochondrial calcium activities in clonal pancreatic beta-cells. Vitam. Horm. 2014, 95:63-86.
238. Takeuchi A., Kim B., Matsuoka S. The destiny of Ca released by mitochondria. J. Physiol. Sci. 2014, (in press). 10.1007/s12576-014-0326-7.
239. Chalmers S., Nicholls D.G. The relationship between free and total calcium concentrations in the matrix of liver and brain mitochondria. J. Biol. Chem. 2003, 278:19062-19070.
240. 2+ sequestration and precipitation revisited. FEBS J. 2010, 277:3637-3651.
241. 2+ uniporter. Cell Calcium 2014, 55:139-145.
242. 2+ uniporter (MCU) contribute to metabolism-secretion coupling in clonal pancreatic beta-cells. J. Biol. Chem. 2012, 287:34445-34454.
243. 2+ uniporter by exerting opposite effects on MCU activity. Mol. Cell 2014, 53:726-737.
244. Sancak Y., Markhard A.L., Kitami T., et al. EMRE is an essential component of the mitochondrial calcium uniporter complex. Science 2013, 342:1379-1382.
245. 2+ accumulation regulates ATP synthesis in pancreatic beta cells. Pflugers Arch. 2013, 465:543-554.
246. 2+ stores and triggers apoptosis in insulin-secreting BRIN-BD11 cells. J. Biol. Chem. 2010, 285:30634-30643.
247. 2+ to supramicromolar levels in a pancreatic beta-cell line. Possible role in glucose and agonist-induced insulin secretion. J. Biol. Chem. 1993, 268:22385-22390.
248. Quesada I., Villalobos C., Nunez L., et al. Glucose induces synchronous mitochondrial calcium oscillations in intact pancreatic islets. Cell Calcium 2008, 43:39-47.
249. Maechler P., Kennedy E.D., Pozzan T., Wollheim C.B. Mitochondrial activation directly triggers the exocytosis of insulin in permeabilized pancreatic beta-cells. EMBO J. 1997, 16:3833-3841.
250. 2+ oscillations in the pancreatic beta-cell line, MIN6. Diabetologia 1998, 41:279-286.
251. 2+ oscillations and insulin secretion in pancreatic islets. Biochem. J. 2001, 353:175-180.
252. 2+ in aequorin-expressing INS-1 cells. J. Clin. Invest. 1996, 98:2524-2538.
253. 2+ channels. Mol. Cell 2010, 38:280-290.
254. + antiporter. Science 2009, 326:144-147.
255. 2+ influx mechanisms. Sci. China Life Sci. 2011, 54:763-769.
256. Contreras L., Drago I., Zampese E., Pozzan T. Mitochondria: the calcium connection. Biochim. Biophys. Acta 2010, 1797:607-618.
257. Csordas G., Varnai P., Golenar T., et al. Calcium transport across the inner mitochondrial membrane: molecular mechanisms and pharmacology. Mol. Cell. Endocrinol. 2012, 353:109-113.
258. 2+ permeable channels. FEBS Lett. 2010, 584:1948-1955.
259. 2+-dependent apoptosis and necrosis. Cell Calcium 2011, 50:222-233.
260. Marselli L., Trincavelli L., Santangelo C., et al. The role of peripheral benzodiazepine receptors on the function and survival of isolated human pancreatic islets. Eur. J. Endocrinol. 2004, 151:207-214.
261. Dufer M., Krippeit-Drews P., Lembert N., et al. Diabetogenic effect of cyclosporin A is mediated by interference with mitochondrial function of pancreatic B-cells. Mol. Pharmacol. 2001, 60:873-879.
262. 2+ release channel: new answers to an old question. Cell Calcium 2012, 52:22-27.
263. 2+ exchange. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:436-441.
264. 2+ responses that are propagated into mitochondria. FASEB J. 2014, 10.1096/fj.13-248161.
265. 2+ exchanger increases mitochondrial metabolism and potentiates glucose-stimulated insulin secretion in rat pancreatic islets. Diabetes 2003, 52:965-973.
266. 2+ exchange inhibitor CGP-37157 in rat atrial myocytes. Eur. J. Pharmacol. 2006, 552:15-19.
267. 2+ ATPase and activates ryanodine receptor channels in striated muscle. Mol. Pharmacol. 2011, 79:141-147.
268. 2+ signalling linked to insulin secretion. PLOS ONE 2012, 7:e46649.
269. 2+ signals using a novel red-shifted mitochondrial targeted cameleon. PLOS ONE 2012, 7:e45917.
270. 2+ uptake. Biochem. Soc. Trans. 2012, 40:158-167.
271. Walsh C., Barrow S., Voronina S., et al. Modulation of calcium signalling by mitochondria. Biochim. Biophys. Acta 2009, 1787:1374-1382.
272. 2+-dependent gene expression in response to receptor stimulation. PLOS ONE 2014, 9:e101188.
273. Wiederkehr A., Szanda G., Akhmedov D., et al. Mitochondrial matrix calcium is an activating signal for hormone secretion. Cell Metab. 2011, 13:601-611.
274. Kennedy H.J., Pouli A.E., Ainscow E.K., et al. Glucose generates sub-plasma membrane ATP microdomains in single islet beta-cells. Potential role for strategically located mitochondria. J. Biol. Chem. 1999, 274:13281-13291.
275. Schuit F., De Vos A., Farfari S., et al. Metabolic fate of glucose in purified islet cells. Glucose-regulated anaplerosis in beta cells. J. Biol. Chem. 1997, 272:18572-18579.
276. 2+ with recombinant targeted aequorin: significance for the regulation of pyruvate dehydrogenase activity. Proc. Natl. Acad. Sci. U. S. A. 1996, 93:5489-5494.
277. Denton R.M., McCormack J.G. On the role of the calcium transport cycle in heart and other mammalian mitochondria. FEBS Lett. 1980, 119:1-8.
278. De Marchi U., Thevenet J., Hermant A., et al. Calcium co-regulates oxidative metabolism and ATP synthase-dependent respiration in pancreatic beta cells. J. Biol. Chem. 2014, 289:9182-9194.
279. 2+ controls slow NAD(P)H oscillations in glucose-stimulated mouse pancreatic islets. J. Physiol. 2006, 572:379-392.
280. 2+ oscillations. Biophys. J. 2010, 99:76-84.
281. Tsuboi T., Ravier M.A., Parton L.E., Rutter G.A. Sustained exposure to high glucose concentrations modifies glucose signaling and the mechanics of secretory vesicle fusion in primary rat pancreatic beta-cells. Diabetes 2006, 55:1057-1065.
282. Panten U., Willenborg M., Schumacher K., et al. Acute metabolic amplification of insulin secretion in mouse islets is mediated by mitochondrial export of metabolites, but not by mitochondrial energy generation. Metabolism. 2013, 62:1375-1386.
283. Krippeit-Drews P., Dufer M., Drews G. Parallel oscillations of intracellular calcium activity and mitochondrial membrane potential in mouse pancreatic B-cells. Biochem. Biophys. Res. Commun. 2000, 267:179-183.
284. 2+ concentration precede oscillations in mitochondrial membrane potential in the pancreatic beta-cell. J. Biol. Chem. 2001, 276:34530-34536.
285. Hodson D.J., Tarasov A.I., Gimeno Brias S., et al. Incretin-modulated Beta cell energetics in intact islets of Langerhans. Mol. Endocrinol. 2014, 28:860-871.
286. Halestrap A.P. A pore way to die: the role of mitochondria in reperfusion injury and cardioprotection. Biochem. Soc. Trans. 2010, 38:841-860.
287. Csordas G., Varnai P., Golenar T., et al. Imaging interorganelle contacts and local calcium dynamics at the ER-mitochondrial interface. Mol. Cell 2010, 39:121-132.
288. Csordas G., Renken C., Varnai P., et al. Structural and functional features and significance of the physical linkage between ER and mitochondria. J. Cell Biol. 2006, 174:915-921.
289. 2+ channels. J. Cell Biol. 2006, 175:901-911.
290. de Brito O.M., Scorrano L. An intimate liaison: spatial organization of the endoplasmic reticulum-mitochondria relationship. EMBO J. 2010, 29:2715-2723.
291. 2+ from the endoplasmic reticulum to mitochondria: is spatial intimacy enough?. Biochem. Soc. Trans. 2006, 34:351-355.
292. 2+ entry in HeLa cells. Cell Calcium 2004, 36:499-508.
293. Rutter G.A., Pinton P. Mitochondria-associated endoplasmic reticulum membranes in insulin signaling. Diabetes 2014, (in press).
294. de Brito O.M., Scorrano L. Mitofusin 2 tethers endoplasmic reticulum to mitochondria. Nature 2008, 456:605-610.
295. 2+ and stimulates mitochondrial ATP synthesis in pancreatic MIN6 beta-cells. Biochem. J. 2003, 369:287-299.
296. 2+ channels in endoplasmic reticulum stress and beta-cell death. Diabetes 2009, 58:422-432.
297. Johnson J.D., Bround M.J., White S.A., Luciani D.S. Nanospaces between endoplasmic reticulum and mitochondria as control centres of pancreatic beta-cell metabolism and survival. Protoplasma 2012, 249(Suppl. 1):S49-S58.
298. Hodson D.J., Mitchell R.K., Marselli L., et al. ADCY5 couples glucose to insulin secretion in human islets. Diabetes 2014, 63(9):3009-3021.
299. Peyot M.L., Gray J.P., Lamontagne J., et al. Glucagon-like peptide-1 induced signaling and insulin secretion do not drive fuel and energy metabolism in primary rodent pancreatic beta-cells. PLoS ONE 2009, 4:e6221.
300. Ashcroft F.M., Rorsman P. Diabetes mellitus and the beta cell: the last ten years. Cell 2012, 148:1160-1171.
301. van de Bunt M., Gloyn A.L. A tale of two glucose transporters: how GLUT2 re-emerged as a contender for glucose transport into the human beta cell. Diabetologia 2012, 55:2312-2315.
302. Sansbury F.H., Flanagan S.E., Houghton J.A., et al. SLC2A2 mutations can cause neonatal diabetes, suggesting GLUT2 may have a role in human insulin secretion. Diabetologia 2012, 55:2381-2385.
303. Shammas C., Neocleous V., Phelan M.M., et al. A report of 2 new cases of MODY2 and review of the literature: implications in the search for type 2 diabetes drugs. Metabolism. 2013, 62:1535-1542.
304. Ashcroft F.M. New uses for old drugs: neonatal diabetes and sulphonylureas. Cell Metab. 2010, 11:179-181.
305. Stoy J., Steiner D.F., Park S.Y., et al. Clinical and molecular genetics of neonatal diabetes due to mutations in the insulin gene. Rev. Endocr. Metab. Disord. 2010, 11:205-215.
306. 2+ signalling, glucose metabolism and insulin secretion in a murine model of K(ATP) channel-induced neonatal diabetes mellitus. Diabetologia 2011, 54:1087-1097.
307. Njolstad P.R., Sagen J.V., Bjorkhaug L., et al. Permanent neonatal diabetes caused by glucokinase deficiency: inborn error of the glucose-insulin signaling pathway. Diabetes 2003, 52:2854-2860.
308. Njolstad P.R., Sovik O., Cuesta-Munoz A., et al. Neonatal diabetes mellitus due to complete glucokinase deficiency. N. Engl. J. Med. 2001, 344:1588-1592.
309. De Vos A., Heimberg H., Quartier E., et al. Human and rat beta cells differ in glucose transporter but not in glucokinase gene expression. J. Clin. Invest. 1995, 96:2489-2495.
310. Bensellam M., Laybutt D.R., Jonas J.C. The molecular mechanisms of pancreatic beta-cell glucotoxicity: recent findings and future research directions. Mol. Cell. Endocrinol. 2012, 364:1-27.
311. Warnotte C., Gilon P., Nenquin M., Henquin J.C. Mechanisms of the stimulation of insulin release by saturated fatty acids. A study of palmitate effects in mouse beta-cells. Diabetes 1994, 43:703-711.
312. 2+ currents and the size of the readily releasable granule pool in mouse pancreatic beta-cells. J. Physiol. 2004, 557:935-948.
313. Nolan C.J., Madiraju M.S., Delghingaro-Augusto V., et al. Fatty acid signaling in the beta-cell and insulin secretion. Diabetes 2006, 55(Suppl. 2):S16-S23.
314. Poitout V. Lipotoxicity impairs incretin signalling. Diabetologia 2013, 56:231-233.
315. Olofsson C.S., Collins S., Bengtsson M., et al. Long-term exposure to glucose and lipids inhibits glucose-induced insulin secretion downstream of granule fusion with plasma membrane. Diabetes 2007, 56:1888-1897.
316. Poitout V., Amyot J., Semache M., et al. Glucolipotoxicity of the pancreatic beta cell. Biochim. Biophys. Acta 2010, 1801:289-298.
317. Cnop M., Ladriere L., Igoillo-Esteve M., et al. Causes and cures for endoplasmic reticulum stress in lipotoxic beta-cell dysfunction. Diabetes Obes. Metab. 2010, 12(Suppl. 2):76-82.
318. Gonzalez A., Merino B., Marroqui L., et al. Insulin hypersecretion in islets from diet-induced hyperinsulinemic obese female mice is associated with several functional adaptations in individual beta-cells. Endocrinology 2013, 154:3515-3524.
319. Bitar M.S., Al-Saleh E., Al-Mulla F. Oxidative stress-mediated alterations in glucose dynamics in a genetic animal model of type II diabetes. Life Sci. 2005, 77:2552-2573.
320. 2+-secretion coupling is impaired in diabetic Goto Kakizaki rats. J. Gen. Physiol. 2007, 129:493-508.
321. 2+ response to glucose in diabetic GK rat. Biochem. Biophys. Res. Commun. 1997, 239:129-133.
322. 2+ handling in islets of GK and nSTZ rat models of type 2 diabetes. J. Endocrinol. 2001, 169:169-176.
323. 2+ channel activities in pancreatic beta cells of non-insulin-dependent diabetes mellitus GK rats. J. Clin. Invest. 1996, 97:2417-2425.
324. Portha B., Lacraz G., Kergoat M., et al. The GK rat beta-cell: a prototype for the diseased human beta-cell in type 2 diabetes?. Mol. Cell. Endocrinol. 2009, 297:73-85.
325. Do O.H., Low J.T., Gaisano H.Y., Thorn P. The secretory deficit in islets from db/db mice is mainly due to a loss of responding beta cells. Diabetologia 2014, 57:1400-1409.
326. i and NADH responses to glucose but not to alpha-ketoisocaproic acid. Pancreas 2005, 31:242-250.
327. 2+ sequestration in diabetic mouse islets of Langerhans. J. Biol. Chem. 1994, 269:18279-18282.
328. 2+ channel activity. Am. J. Physiol. 1996, 270:E133-E140.
329. Jahanshahi P., Wu R., Carter J.D., Nunemaker C.S. Evidence of diminished glucose stimulation and endoplasmic reticulum function in nonoscillatory pancreatic islets. Endocrinology 2009, 150:607-615.
330. 2+ dynamics in age-induced diabetes. Diabetes 2014, 10.2337/db13-1855.
331. Allagnat F., Alonso F., Martin D., et al. ICER-1gamma overexpression drives palmitate-mediated connexin36 down-regulation in insulin-secreting cells. J. Biol. Chem. 2008, 283:5226-5234.
332. 2+ oscillations and pulsatile insulin secretion in islets from ob/ob mice. Diabetologia 2002, 45:1154-1163.
333. Khaldi M.Z., Guiot Y., Gilon P., et al. Increased glucose sensitivity of both triggering and amplifying pathways of insulin secretion in rat islets cultured for 1 wk in high glucose. Am. J. Physiol. Endocrinol. Metab. 2004, 287:E207-E217.
334. Cunha D.A., Hekerman P., Ladriere L., et al. Initiation and execution of lipotoxic ER stress in pancreatic beta-cells. J. Cell Sci. 2008, 121:2308-2318.
335. 2+ homeostasis in beta-cells. Am. J. Physiol. Endocrinol. Metab. 2009, 296:E690-E701.
336. Hara T., Mahadevan J., Kanekura K., et al. Calcium efflux from the endoplasmic reticulum leads to beta-cell death. Endocrinology 2014, 155:758-768.
337. 2+ release through the c-Jun N-terminal kinase pathway. Mol. Cell. Biochem. 2009, 324:183-190.
338. 2+-ATPases in pancreatic beta-cells and in islets of Langerhans. Biochim. Biophys. Acta 1995, 1236:119-127.
339. 2+-transport ATPase 3 gene (SERCA3) in Caucasian type II diabetic patients (UK Prospective Diabetes Study 48). Diabetologia 1999, 42:1240-1243.
340. Supale S., Li N., Brun T., Maechler P. Mitochondrial dysfunction in pancreatic beta cells. Trends Endocrinol. Metab. 2012, 23:477-487.
341. Molina A.J., Wikstrom J.D., Stiles L., et al. Mitochondrial networking protects beta-cells from nutrient-induced apoptosis. Diabetes 2009, 58:2303-2315.
342. Csordas G., Hajnoczky G. SR/ER-mitochondrial local communication: calcium and ROS. Biochim. Biophys. Acta 2009, 1787:1352-1362.
343. Fujimoto S., Mukai E., Inagaki N. Role of endogenous ROS production in impaired metabolism-secretion coupling of diabetic pancreatic beta cells. Prog. Biophys. Mol. Biol. 2011, 107:304-310.
344. Li N., Frigerio F., Maechler P. The sensitivity of pancreatic beta-cells to mitochondrial injuries triggered by lipotoxicity and oxidative stress. Biochem. Soc. Trans. 2008, 36:930-934.
345. Koshkin V., Dai F.F., Robson-Doucette C.A., et al. Limited mitochondrial permeabilization is an early manifestation of palmitate-induced lipotoxicity in pancreatic beta-cells. J. Biol. Chem. 2008, 283:7936-7948.